Lytix Biopharma AS (FRA:6BG)
Germany
· Delayed Price · Currency is EUR 0.850
-0.038 (-4.28%)
Last updated: Dec 5, 2025, 8:03 AM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of €59.18 million as of December 5, 2025. Its market cap has increased by 137.58% in one year.
Market Cap
59.18M
Enterprise Value
51.74M
Revenue
32.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.85
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 71.47M to 59.18M, a decrease of -17.19%. That is a compound annual growth rate of -4.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 59.15M | 73.88% |
| Dec 30, 2024 | 34.01M | 95.78% |
| Dec 29, 2023 | 17.37M | -41.17% |
| Dec 30, 2022 | 29.53M | -44.70% |
| Dec 30, 2021 | 53.40M | -25.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |